Drug
CG100649 clinical trials
Also written CG100649.
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
CrystalGenomics, Inc. (6) · University of Pennsylvania (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Cyclooxygenase 2 Inhibitors source
- One of Cyclooxygenase Inhibitors source
Studies
Open first, then newest update. How each study uses CG100649 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649CompletedPhase 1CrystalGenomics, Inc.NCT01154764Written as CG100649
- Phase III Study of CG100649 in Osteoarthritis PatientsCompletedPhase 3CrystalGenomics, Inc.NCT01765296Written as CG100649
- Study of CG100649 Versus Celecoxib in Osteoarthritis PatientsCompletedPhase 2CrystalGenomics, Inc.NCT01341405Written as CG100649
- Drug-Drug Interaction Study of "CG-651" in Healthy VolunteerCompletedPhase 1CrystalGenomics, Inc.NCT05370716Written as Polmacoxib
- Phase I Study on Multiple Oral Dosing of CG100649CompletedPhase 1CrystalGenomics, Inc.NCT01154790Written as CG100649
- Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase InhibitionTerminatedPhase 1University of PennsylvaniaNCT00780325Written as CG100649 (2 mg)
- Phase II Study of CG100649 for Primary Osteoarthritis in Male SubjectsStatus unknownPhase 2CrystalGenomics, Inc.NCT00530452Written as CG100649